Auxier Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.63M | Sell |
8,869
-42
| -0.5% | -$7.74K | 0.23% | 91 |
|
|
2025
Q4 | $1.57M | Sell |
8,911
-1,251
| -12% | -$204K | 0.22% | 90 |
|
|
2025
Q3 | $1.42M | Sell |
10,162
-70
| -0.7% | -$9.46K | 0.2% | 96 |
|
|
2025
Q2 | $1.29M | Sell |
10,232
-3,315
| -24% | -$413K | 0.19% | 94 |
|
|
2025
Q1 | $1.85M | Sell |
13,547
-499
| -4% | -$71.3K | 0.28% | 79 |
|
|
2024
Q4 | $2.15M | Sell |
14,046
-2,136
| -13% | -$360K | 0.33% | 74 |
|
|
2024
Q3 | $3.14M | Sell |
16,182
-38
| -0.2% | -$7.95K | 0.46% | 57 |
|
|
2024
Q2 | $3.76M | Sell |
16,220
-385
| -2% | -$83.7K | 0.6% | 47 |
|
|
2024
Q1 | $3.58M | Sell |
16,605
-5,053
| -23% | -$1.18M | 0.54% | 52 |
|
|
2023
Q4 | $5.6M | Sell |
21,658
-102
| -0.5% | -$25.1K | 0.91% | 35 |
|
|
2023
Q3 | $5.59M | Sell |
21,760
-25
| -0.1% | -$6.69K | 0.95% | 33 |
|
|
2023
Q2 | $6.21M | Sell |
21,785
-510
| -2% | -$152K | 1.03% | 31 |
|
|
2023
Q1 | $6.2M | Sell |
22,295
-50
| -0.2% | -$13.8K | 1.07% | 29 |
|
|
2022
Q4 | $6.19M | Sell |
22,345
-1,355
| -6% | -$383K | 1.07% | 30 |
|
|
2022
Q3 | $6.33M | Sell |
23,700
-40
| -0.2% | -$8.49K | 1.22% | 27 |
|
|
2022
Q2 | $4.84M | Sell |
23,740
-70
| -0.3% | -$14.3K | 0.86% | 36 |
|
|
2022
Q1 | $5.01M | Hold |
23,810
| – | – | 0.8% | 39 |
|
|
2021
Q4 | $5.71M | Sell |
23,810
-175
| -0.7% | -$45K | 0.89% | 35 |
|
|
2021
Q3 | $6.79M | Sell |
23,985
-145
| -0.6% | -$47.5K | 1.15% | 24 |
|
|
2021
Q2 | $8.36M | Sell |
24,130
-237
| -1% | -$71.8K | 1.39% | 19 |
|
|
2021
Q1 | $6.82M | Sell |
24,367
-20
| -0.1% | -$5.39K | 1.17% | 25 |
|
|
2020
Q4 | $5.97M | Buy |
24,387
+120
| +0.5% | +$31K | 1.11% | 27 |
|
|
2020
Q3 | $6.88M | Sell |
24,267
-45
| -0.2% | -$12.6K | 1.44% | 18 |
|
|
2020
Q2 | $6.5M | Sell |
24,312
-1,950
| -7% | -$586K | 1.44% | 18 |
|
|
2020
Q1 | $8.31M | Sell |
26,262
-1,155
| -4% | -$351K | 2.07% | 11 |
|
|
2019
Q4 | $8.13M | Hold |
27,417
| – | – | 1.51% | 18 |
|
|
2019
Q3 | $6.38M | Buy |
27,417
+200
| +0.7% | +$46.6K | 1.28% | 24 |
|
|
2019
Q2 | $6.37M | Buy |
27,217
+960
| +4% | +$222K | 1.27% | 23 |
|
|
2019
Q1 | $6.21M | Buy |
26,257
+100
| +0.4% | +$31.5K | 1.28% | 23 |
|
|
2018
Q4 | $7.87M | Sell |
26,157
-2,000
| -7% | -$638K | 1.75% | 17 |
|
|
2018
Q3 | $9.95M | Hold |
28,157
| – | – | 1.88% | 15 |
|
|
2018
Q2 | $8.17M | Sell |
28,157
-68
| -0.2% | -$19.1K | 1.64% | 18 |
|
|
2018
Q1 | $7.73M | Buy |
28,225
+70
| +0.2% | +$21.7K | 1.55% | 19 |
|
|
2017
Q4 | $8.97M | Buy |
28,155
+10
| +0% | +$3.21K | 1.72% | 18 |
|
|
2017
Q3 | $8.81M | Sell |
28,145
-25
| -0.1% | -$7.4K | 1.79% | 14 |
|
|
2017
Q2 | $7.64M | Buy |
28,170
+2,295
| +9% | +$607K | 1.56% | 16 |
|
|
2017
Q1 | $7.08M | Buy |
25,875
+570
| +2% | +$161K | 1.48% | 17 |
|
|
2016
Q4 | $7.18M | Buy |
25,305
+2,670
| +12% | +$791K | 1.56% | 17 |
|
|
2016
Q3 | $7.08M | Buy |
22,635
+4,650
| +26% | +$1.38M | 1.59% | 15 |
|
|
2016
Q2 | $4.35M | Buy |
17,985
+8,970
| +100% | +$2.36M | 1% | 38 |
|
|
2016
Q1 | $2.35M | Buy |
9,015
+1,820
| +25% | +$481K | 0.56% | 56 |
|
|
2015
Q4 | $2.2M | Buy |
+7,195
| New | +$2.07M | 0.5% | 60 |
|
Other funds holding BIIB
VCM
VPM
Auxier Asset Management's BIIB Position: Q1 2026 in Review
Auxier Asset Management reduced its Biogen (BIIB) stake by 0.47% in Q1 2026, selling an estimated $7.74K and leaving 8,869 shares worth $1.63M. The position accounts for 0.23% of the portfolio, ranked #91.
Auxier Asset Management first reported a position in BIIB in Q4 2015 and has held it in 42 quarters since. The position peaked at $9.95M in Q3 2018. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Auxier Asset Management held 8,869 shares of Biogen worth $1.63M as of Q1 2026.
- Auxier Asset Management sold 42 Biogen shares in Q1 2026, an estimated $7.74K.
- Biogen made up 0.23% of Auxier Asset Management's portfolio in Q1 2026, its #91 holding.
- Auxier Asset Management first reported a position in Biogen in Q4 2015 and has held it in 42 quarters since.
- Auxier Asset Management's Biogen position peaked at $9.95M in Q3 2018.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Auxier Asset Management's 13F filing for Q1 2026, filed 14 May 2026.